New Research Published in Ophthalmology Shows Genetic Testing Can Help Predict Glaucoma Risk, Progression and Surgery
SAN DIEGO--(BUSINESS WIRE)--Seonix Bio, a leader in the development of genetic testing for glaucoma, today announced new research published in Ophthalmology, the American Academy of Ophthalmology’s peer-reviewed journal. The publication reports that the polygenic risk score (PRS) underlying the company’s SightScore™ test can help identify people at substantially different levels of risk for developing glaucoma—and may also help predict disease progression and the likelihood of surgery. Glaucoma